<mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-8.xsd"><mods:titleInfo><mods:title>I’m Paying How Much???: A Cross-Sectional Survey Focusing on Medication Cost for Patients Prescribed GLP-1 Agonists</mods:title></mods:titleInfo><mods:typeOfResource authority="primo">images</mods:typeOfResource><mods:abstract>Background: An annual report in 2022 revealed that 9 out of 10 Americans would like to know their financial responsibility upfront, but only 2 out of those 10 Americans will know their financial responsibility at the end of the visit. This begs the question, why are so many patients leaving their clinic visit susceptible to future unexpected costs? This study aims to look at patients who are prescribed Glucagon-like peptide 1 agonists (GLP-1) and the prevalence of unexpected or ""surprise"" medication costs.
Methods: We investigated unexpected prescription drug costs for patents taking GLP-1 agonists using a literature review and a cross-sectional survey that consisted of both quantitative and qualitative responses. The survey was administered to patients previously or currently prescribed a GLP-1 agonist from a community-based practice in Providence, RI. The patients surveyed were provided via a convenience sample.
Results: 15% (N = 6) of patients reported paying more than expected for their medications although those prices ranged from $5 to $1000. Patients' cost of medication responses ranged from $0 to $1200, and patients’ willingness to pay more than their expected cost of medication out of pocket ranged from $20 to $1000. 7.5% (N = 3) of patients stated that they would be willing to pay anything. 33% (N = 13) of patients always knew their medication cost while 27.5% (N = 11) of patients never or rarely knew their medication cost prior to pick-up. 60% (N = 24) of patients had no prior medication cost research. These data were collected using Qualtrics and analyzed using Google Sheets.
Conclusion: Although most patients did not encounter an unexpected cost, there is a minority of patients where this is an issue. The study provides an avenue for future research on what interventions can be implemented to mitigate unexpected cost.</mods:abstract><mods:name><mods:namePart>Dunwell, Stanley</mods:namePart><mods:role><mods:roleTerm authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/aut">Author</mods:roleTerm></mods:role></mods:name><mods:name><mods:namePart>Bledsoe, Thomas</mods:namePart><mods:role><mods:roleTerm authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/aut">Author</mods:roleTerm></mods:role></mods:name><mods:name><mods:namePart>Gutman, Deborah</mods:namePart><mods:role><mods:roleTerm authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/aut">Author</mods:roleTerm></mods:role></mods:name><mods:originInfo><mods:dateCreated>2024</mods:dateCreated></mods:originInfo><mods:subject authority="local"><mods:topic>insurance</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>chronic disease</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>diabetes mellitus</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Financing</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Cost of Illness</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Cost Savings</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>GLP-1 Agonists</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Health care costs</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Health care expenditure</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Medical decision-making</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Out-of-pocket costs</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Price transparency</mods:topic></mods:subject><mods:subject authority="local"><mods:topic>Unexpected Costs</mods:topic></mods:subject><mods:genre>posters</mods:genre><mods:accessCondition type="use and reproduction">All rights reserved</mods:accessCondition><mods:accessCondition type="rights statement" xlink:href="http://rightsstatements.org/vocab/InC/1.0/">In Copyright</mods:accessCondition><mods:accessCondition type="restriction on access">All Rights Reserved</mods:accessCondition><mods:identifier type="doi">10.26300/p3pd-mp85</mods:identifier></mods:mods>